Nations Financial Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-23,386
| Closed | -$23.9K | – | 696 |
|
2024
Q4 | $23.9K | Hold |
23,386
| – | – | ﹤0.01% | 664 |
|
2024
Q3 | $20.3K | Buy |
23,386
+9,136
| +64% | +$7.91K | ﹤0.01% | 668 |
|
2024
Q2 | $5.11K | Hold |
14,250
| – | – | ﹤0.01% | 629 |
|
2024
Q1 | $9.55K | Sell |
14,250
-402
| -3% | -$269 | ﹤0.01% | 620 |
|
2023
Q4 | $7.96K | Buy |
14,652
+3,010
| +26% | +$1.64K | ﹤0.01% | 618 |
|
2023
Q3 | $6.98K | Hold |
11,642
| – | – | ﹤0.01% | 612 |
|
2023
Q2 | $15.1K | Buy |
11,642
+200
| +2% | +$260 | ﹤0.01% | 611 |
|
2023
Q1 | $20.1K | Buy |
+11,442
| New | +$20.1K | ﹤0.01% | 612 |
|